Post

New research · Ophthalmology
Carbohydrate polymers · 2d
Animal / preclinicalCarbohydrate polymers · 2026

Helical-cavity-preserving starch engineering enables root-inspired multilevel wet bioadhesion for corneal repair.

Baolei Huang, Wenjing Song, Wenfang Liu … Li Ren
Read paper
OphthalmologyAnimal / preclinical

New starch-based adhesive achieves strong wet bonding to seal corneal wounds without sutures.

Helical-cavity-preserving starch engineering enables root-inspired multilevel wet bioadhesion for corneal repair.

Baolei Huang … Li Ren
Carbohydrate polymers · 2026
Background

Polysaccharide-based adhesives hold promise for wet tissue repair, yet their application is often limited by weak interfacial bonding and insufficient cohesive strength in hydrated environments.

166
Results
166
kPa
how much force it took to pull the seal apart underwater - higher means stronger, more secure bonding
More results

Here, we report a root-inspired multilevel wet bioadhesive enabled by helical-cavity-preserving starch engineering for corneal repair.

“
Conclusion

This study establishes helical-cavity-preserving starch as an active carbohydrate-polymer motif for root-inspired wet bioadhesive design.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving